Literature DB >> 6197455

Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies.

L H Kasper, M S Bradley, E R Pfefferkorn.   

Abstract

Stage-specific antigens of Toxoplasma gondii have not been reported. We developed a panel of monoclonal antibodies that identified unique surface membrane antigens on the sporozoite and oocyst wall of T. gondii. These monoclonal antibodies failed to react with T. gondii tachyzoite surface membrane antigens in several immunologic assays. A comparison of surface membrane radioiodinated tachyzoites and sporozoites by one- and two-dimensional electrophoresis showed that T. gondii sporozoites have two major membrane proteins of approximate m.w. 67,000 and 25,000, not present in the tachyzoite stage. Two of the stage-specific monoclonal antibodies (2E4 and 5A4) were directed against the sporozoite 67,000 m.w. protein. In addition, T. gondii sporozoites are deficient in the major radioiodinated tachyzoite protein P30, which is identified by both human and mouse convalescent antitoxoplasma antisera. A convalescent antitoxoplasma serum failed to recognize sporozoite antigens by both immunoprecipitation and reaction with nitrocellulose transfer blots.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Identification and biochemical characterization of antigens of tachyzoites and bradyzoites of Toxoplasma gondii with cross-reactive epitopes.

Authors:  F Darcy; H Charif; H Caron; D Deslée; R J Pierce; M F Cesbron-Delauw; A Decoster; A Capron
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Detection of species-specific and cross-reactive epitopes in Sarcocystis cystozoites by monoclonal antibodies.

Authors:  A M Tenter; C Vietmeyer; P Thümmel; M Rommel
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

4.  Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii.

Authors:  A Makioka; A Kobayashi
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

5.  Characterization of bradyzoite-specific antigens of Toxoplasma gondii.

Authors:  S Tomavo; B Fortier; M Soete; C Ansel; D Camus; J F Dubremetz
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins.

Authors:  M Tilley; M E Fichera; M E Jerome; D S Roos; M W White
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Biological role of surface Toxoplasma gondii antigen in development of vaccine.

Authors:  Ke-Yi Liu; Dian-Bo Zhang; Qing-Kuan Wei; Jin Li; Gui-Ping Li; Jin-Zhi Yu
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

8.  Identification of stage-specific antigens of Toxoplasma gondii.

Authors:  L H Kasper
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

9.  A novel dense granule protein, GRA41, regulates timing of egress and calcium sensitivity in Toxoplasma gondii.

Authors:  Kaice A LaFavers; Karla M Márquez-Nogueras; Isabelle Coppens; Silvia N J Moreno; Gustavo Arrizabalaga
Journal:  Cell Microbiol       Date:  2017-05-17       Impact factor: 3.715

10.  Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

Authors:  Kevin N Couper; Paula A Lanthier; Georgia Perona-Wright; Lawrence W Kummer; Wangxue Chen; Stephen T Smiley; Markus Mohrs; Lawrence L Johnson
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.